We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

Novartis Ireland Limited

Vista Building, Elm Park Business Park, Merrion Road, Dublin 4, Ireland
Telephone: +353 1 2601255
Fax: +353 1 2601263
Medical Information e-mail: medinfo.dublin@novartis.com
Patient Information Leaflet last updated on medicines.ie: 11/10/2017
PIL Hycamtin 1mg and 4mg vial

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 11/10/2017 and displayed until Current
Reasons for adding or updating:
  • Change to section 6 - marketing authorisation number
  • Change to section 6 - date of revision
Updated on 25/05/2016 and displayed until 11/10/2017
Reasons for adding or updating:
  • Change to marketing authorisation holder
Updated on 16/11/2015 and displayed until 25/05/2016
Reasons for adding or updating:
  • Previous version of PIL reinstated
Updated on 06/10/2014 and displayed until 16/11/2015
Reasons for adding or updating:
  • Addition of information on reporting a side effect.
  • Change to date of revision
  • Transfer of Marketing Authorisation Holder
Updated on 06/01/2014 and displayed until 06/10/2014
Reasons for adding or updating:
  • Change to side-effects
Updated on 30/08/2013 and displayed until 06/01/2014
Reasons for adding or updating:
  • Change of distributor details
Updated on 07/02/2011 and displayed until 30/08/2013
Reasons for adding or updating:
  • Change to side-effects
Updated on 07/04/2009 and displayed until 07/02/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to dosage and administration
  • Change to appearance of the medicine
  • Change to side-effects
  • Change to packaging
Updated on 21/08/2008 and displayed until 07/04/2009
Reasons for adding or updating:
  • Change to information about pregnancy or lactation
Updated on 12/06/2008 and displayed until 21/08/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 04/04/2007 and displayed until 12/06/2008
Reasons for adding or updating:
  • Change to side-effects
Updated on 04/08/2005 and displayed until 04/04/2007
Reasons for adding or updating:
  • Improved electronic presentation
Updated on 28/10/2004 and displayed until 04/08/2005
Reasons for adding or updating:
  • New PIL for medicines.ie

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Topotecan Hydrochloride